Viewing Study NCT01310309



Ignite Creation Date: 2024-05-05 @ 11:21 PM
Last Modification Date: 2024-10-26 @ 10:32 AM
Study NCT ID: NCT01310309
Status: COMPLETED
Last Update Posted: 2012-12-21
First Post: 2011-03-03

Brief Title: EXecutive Registry Evaluating XIENCE V in a Multi Vessel Disease
Sponsor: Abbott Medical Devices
Organization: Abbott Medical Devices

Study Overview

Official Title: EXecutive Registry XIENCE V Everolimus Eluting Coronary Stent System XIENCE V EECSS in the Treatment of the Specific Setting of Patients With Multi-vessel Coronary Artery Disease
Status: COMPLETED
Status Verified Date: 2012-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: EXecutive
Brief Summary: The purpose of this two part study is the assessment of the performance of the XIENCE V Everolimus Eluting Coronary Stent System XIENCE V EECSS in the treatment of the specific setting of patients with Multi-Vessel Coronary Artery Disease MVD
Detailed Description: This is a clinical evaluation of the XIENCE V everolimus eluting coronary stent system as a revascularization treatment of patients with multi-vessel coronary artery disease MVD-CAD

The sutdy is composed of two parts

A Randomized Controlled Trial outlined in a separate posting and the registry portion of this study which is as follows

-A prospective controlled registry to analyze the clinical efficacy and safety at mid and long-term follow-up in patients with MVD treated with the XIENCE V Everolimus Eluting Coronary Stent System XIENCE V EECSS

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None